NCT07526155 is a NA clinical trial of Deep Brain Stimulation (DBS) in Essential Tremor (ET), sponsored by Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental.

What drugs are being tested in NCT07526155?

Interventions in NCT07526155: Deep Brain Stimulation (DBS).

What condition does NCT07526155 study?

NCT07526155 studies Essential Tremor (ET).

Is NCT07526155 still recruiting?

NCT07526155 is currently completed. Last updated 13 April 2026.

Last reviewed 2026-04-13 · How we verify

NCT07526155

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Trial to Compare VIM vs PSA Bilateral Deep Brain Stimulation in Patients With Essential Tremor

Completed NA Last updated 13 April 2026

What this trial tests

NA trial testing Deep Brain Stimulation (DBS) in Essential Tremor (ET) in 11 participants. Completed in 24 July 2024.

Timeline

27 May 2020

Primary endpoint
20 December 2023

24 July 2024

Quick facts

Lead sponsor	Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	triple
Primary purpose	treatment
Enrollment	11
Start date	27 May 2020
Primary completion	20 December 2023
Estimated completion	24 July 2024
Sites	1 location across Spain

Drugs / interventions tested

Deep Brain Stimulation (DBS)

Conditions studied

Essential Tremor (ET) — all drugs for Essential Tremor (ET) →

Sponsor

Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental

Who can join

18 and older, any sex, with Essential Tremor (ET). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Deep brain stimulation (DBS) of both ventral intermediate nucleus (VIM) and the posterior subthalamic area (PSA) has shown to be an effective treatment for essential tremor (ET). Characterizing the differences between both targets is necessary. The aim of the study is comparison of efficacy, safety, energy efficiency, neuropsychological status and quality of life of bilateral PSA-DBS vs bilateral VIM-DBS in the treatment of ET. The study hypothesis is that PSA-DBS is not inferior to VIM-DBS in terms of efficacy in controlling tremor, but has superior energy efficiency and safety.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Deep Brain Stimulation (DBS)

Trials testing the same drug.

NCT07109804 — Cuneiform Nucleus (CnF) Deep Brain Stimulation for Gait Facilitation Following Spinal Cord Injury · NA · recruiting
NCT06911229 — Neurophysiology of Locomotor Adaptation and Freezing of Gait in Parkinson's Disease · NA · recruiting
NCT06542900 — Efficacy of Deep Brain Stimulation(DBS) for Treatment-Resistant Depression(TRD) · NA · not yet recruiting
NCT06361004 — Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome · NA · not yet recruiting
NCT05623306 — SEEG-Guided DBS for OCD · NA · recruiting

Other Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental trials

Trials by the same sponsor.

NCT06997458 — Liquid BiOpsy, Lung and Colon Cancer in AndaluciA · enrolling by invitation
NCT06722443 — Impact of Nutritional Intervention With Probiotics and Prebiotics on Obesity. · NA · enrolling by invitation
NCT06639126 — Intervention Study Focused on the Intestinal Microbiome to Evaluate the Impact of a Wild Thyme Extract (Thymus Serpyllum · NA · enrolling by invitation
NCT05628818 — Noninvasive Transcranial Direct Current Stimulation to Improve Executive Functions in Stroke Patients. MODUL-EXE Clinica · NA · unknown
NCT04894357 — Impact of V106I on Resistance to Doravirine · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07526155 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Last refreshed: 13 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07526155.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing